← FDA DRUG APPROVALS

FDA ANDA · ANDA072352

PRAZOSIN HYDROCHLORIDE

Sponsor: WATSON LABS

APPLICATION
ANDA072352
TYPE
ANDA
ORIGINAL APPROVAL
1989-01-11
LATEST ACTION
1991-01-28
ROUTE
ORAL
DOSAGE FORM
CAPSULE
MARKETING STATUS
Discontinued

Products

PRAZOSIN HYDROCHLORIDEDiscontinued
PRAZOSIN HYDROCHLORIDE EQ 1MG BASE · CAPSULE · ORAL

Approval history

1991-01-28Manufacturing (CMC) · Supplement 6AP
1990-08-31Manufacturing (CMC) · Supplement 4AP
1990-06-29Manufacturing (CMC) · Supplement 3AP
1990-05-24Manufacturing (CMC) · Supplement 2AP
1990-05-24Labeling · Supplement 1AP
1989-01-11OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →